Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Gilead Sciences a Good Stock to Buy Now?

TheMotleyFool

0 0

Is Gilead Sciences a Good Stock to Buy Now?: https://g.foolcdn.com/editorial/images/719491/investor-in-deep-thought-getty.jpg

Shares of Gilead Sciences (NASDAQ: GILD) marched higher on Thursday, Feb. 2 in response to a fourth-quarter earnings report that exceeded expectations. A day later, the U.S. Food and Drug Administration (FDA) agreed to dramatically increase the addressable patient population for an important cancer drug called Trodelvy.

Gilead Sciences splashed out with a $21 billion acquisition of Immunomedics in 2020 for access to Trodelvy. Long considered a leader in the antiviral drug niche, management is betting heavily that Trodelvy can open up new avenues to growth.

Is Gilead Sciences a smart stock to buy now that Trodelvy is approved to treat a larger audience? Here's what you should know.

Source Fool.com

Like: 0

GILD

Share